Tumor-specific activation of prodrugs: is there a role for nuclear medicine?

被引：2
|
作者：
Antunes, Ines F. [1 ]
Haisma, Hidde J. [2 ]
de Vries, Erik F. J. [1 ]
机构：
[1] Univ Med Ctr Groningen, Dept Nucl Med & Mol Imaging, NL-9713 GZ Groningen, Netherlands
[2] Univ Groningen, Univ Ctr Pharm, Dept Therapeut Gene Modulat, Groningen, Netherlands
来源：
NUCLEAR MEDICINE COMMUNICATIONS | 2008年 / 29卷 / 10期
关键词：
D O I：
10.1097/MNM.0b013e3283094efc
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：845 / 846
页数：2
相关论文
共 50 条
  • [1] PRODRUGS OF ANTHRACYCLINE ANTIBIOTICS SUITED FOR TUMOR-SPECIFIC ACTIVATION
    AZOULAY, M
    FLORENT, JC
    MONNERET, C
    GESSON, JP
    JACQUESY, JC
    TILLEQUIN, F
    KOCH, M
    BOSSLET, K
    CZECH, J
    HOFFMAN, D
    ANTI-CANCER DRUG DESIGN, 1995, 10 (06): : 441 - 450
  • [2] ROS-activated anticancer prodrugs: a new strategy for tumor-specific damage
    Peng, Xiaohua
    Gandhi, Varsha
    THERAPEUTIC DELIVERY, 2012, 3 (07) : 823 - 833
  • [3] Role of monoclonal antibodies in tumor-specific immunity
    Nicodemus, Christopher F.
    Smith, L. Mary
    Schultes, Birgit C.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2007, 7 (03) : 331 - 343
  • [4] Masked Chimeric Antigen Receptor for Tumor-Specific Activation
    Han, Xiaolu
    Bryson, Paul D.
    Zhao, Yifan
    Cinay, Gunce E.
    Li, Si
    Guo, Yunfei
    Siriwon, Natnaree
    Wang, Pin
    MOLECULAR THERAPY, 2017, 25 (01) : 274 - 284
  • [5] Tumor-specific fluorescence activation of rhodamine isothiocyanate derivatives
    Hu, Shiqi
    Jiang, Haiping
    Zhu, Jianqiang
    Wang, Jinqiang
    Wang, Shunhao
    Tang, Jianbin
    Zhou, Zhuxian
    Liu, Sijin
    Shen, Youqing
    Journal of Controlled Release, 2021, 330 : 842 - 850
  • [6] Tumor-specific fluorescence activation of rhodamine isothiocyanate derivatives
    Hu, Shiqi
    Jiang, Haiping
    Zhu, Jianqiang
    Wang, Jinqiang
    Wang, Shunhao
    Tang, Jianbin
    Zhou, Zhuxian
    Liu, Sijin
    Shen, Youqing
    JOURNAL OF CONTROLLED RELEASE, 2021, 330 : 842 - 850
  • [7] ROLE OF TUMOR-SPECIFIC ANTIBODIES IN TUMOR RESISTANCE ENHANCEMENT AND TOLERANCE
    ABDOU, NI
    MCKENNA, JM
    JOURNAL OF ALLERGY, 1967, 39 (02): : 114 - &
  • [8] Novel ROS-activated quinone prodrugs: A new strategy for tumor-specific damage
    Vadukoot, Anish K.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
  • [9] Importance of nuclear localization of apoptin for tumor-specific induction of apoptosis
    Danen-van Oorschot, AAAM
    Zhang, YH
    Leliveld, SR
    Rohn, JL
    Seelen, MCMJ
    Bolk, MW
    van Zon, A
    Erkeland, SJ
    Abrahams, JP
    Mumberg, D
    Noteborn, MHM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (30) : 27729 - 27736
  • [10] Dissecting the role of IKKβ in tumor-specific cell death
    Fields, Peter
    Beattie, Amy
    Limoge, Michelle
    Bakin, Andrei
    FASEB JOURNAL, 2014, 28 (01):
12345